<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">FENTANYL CITRATE</span><br/>(fen'ta-nil)<br/><span class="topboxtradename">Duragesic, </span><span class="topboxtradename">Actiq Oralet, </span><span class="topboxtradename">Sublimaze<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">analgesic</span>; <span class="classification">narcotic (opiate) agonist</span><br/><b>Prototype: </b>Morphine<br/><b>Pregnancy Category: </b>C<br/><b>Controlled Substance: </b>Schedule II<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>0.05 mg/mL injection; 100 mcg, 200 mcg, 300 mcg, 400 mcg lozenges; 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, 1600 mcg lozenges on a stick; 12 mcg/h, 25 mcg/h, 50 mcg/h, 75 mcg/h, 100 mcg/h transdermal patch</p>
<h1><a name="action">Actions</a></h1>
<p>Synthetic, potent narcotic agonist analgesic with pharmacologic actions qualitatively similar to those of morphine and meperidine,
         but action is more prompt and less prolonged. Principal actions: analgesia and sedation. Drug-induced alterations in respiratory
         rate and alveolar ventilation may persist beyond the analgesic effect. Emetic effect is less than with either morphine or
         meperidine.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Provides analgesia and sedation.</p>
<h1><a name="uses">Uses</a></h1>
<p>Short-acting analgesic during operative and perioperative periods, as a narcotic analgesic supplement in general and regional
         anesthesia, and with droperidol or with diazepam to produce neuroleptoanalgesia. Also given with oxygen and a skeletal muscle
         relaxant (neuroleptoanesthesia) to selected high-risk patients (e.g., those undergoing open heart surgery) when attenuation
         of the response to surgical stress without use of additional anesthesia agents is important.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Patients who have received <small>MAO INHIBITORS</small> within 14 d; myasthenia gravis; labor and delivery, lactation. Safety during pregnancy (category C) or in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Head injuries, increased intracranial pressure; older adults, debilitated, poor-risk patients; COPD, other respiratory problems;
         liver and kidney dysfunction; bradyarrhythmias.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Premedication</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM</span> 50100 mcg 3060 min before surgery <span class="rdroute">PO</span> Suck on 400-mcg lozenge until sedated<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> Suck on lozenge until sedated, <i>1025 kg,</i> 200-mcg lozenge; <i>2535 kg,</i> 300-mcg lozenge; <i>3540 kg,</i> 400-mcg lozenge<br/><span class="rdage">Neonate:</span> <span class="rdroute">IV</span> 14-mcg/kg slow IV push q24h or 12-mcg/kg bolus, then infuse at 0.51-mcg/kg/h<br/><span class="rdage">Child:</span> <span class="rdroute">IV/IM</span> <i>112 y</i>, 12 mcg/kg q3060 min or 12 mcg/kg followed by 13 mcg/kg/h infusion (max: 5 mcg/kg/h)<br/><br/><span class="indicationtitle">Adjunct for Regional Anesthesia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM</span> 50100 mcg <span class="rdroute">IV</span> 220 mcg/kg over 12 min up to 50 mcg/kg<br/><br/><span class="indicationtitle">General Anesthesia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> up to 150 mcg/kg as required<br/><br/><span class="indicationtitle">Postoperative Pain</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM</span> 50100 mcg q12h prn<br/><span class="rdage">Child:</span> <span class="rdroute">IM</span> 1.73.3 mcg/kg q12h prn<br/><br/><span class="indicationtitle">Chronic Pain</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Transdermal</span> Individualize and regularly reassess doses of transdermal fentanyl; for patient not already receiving an opioid, the initial
               dose is 25 mcg/h patch q3d; for patients already on opioids, see package insert for conversions <span class="rdroute">Stick lozenge (Actiq)</span> Place in mouth between cheek and lower gum and suck on lozenge; should be consumed over 15-min period<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravascular</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype"> Direct:</span>  Give parenteral doses undiluted or diluted in 5 mL sterile water or NS.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">Direct:</span> Infuse over 12 min.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/additive:</span> <b>Fluorouracil,</b> <b>pentobarbital,</b> <b>thiopental.</b> <span class="incompattype">Y-site:</span> <b>Azithromycin.</b>
</p>
</td>
</tr>
</table>
<ul>
<li>Store at 15°30° C (59°86° F) unless otherwise directed. Protect drug from light.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> <span class="speceff-common">Sedation,</span> euphoria, dizziness, diaphoresis, delirium, convulsions with high doses. <span class="typehead">CV:</span> Hypotension, bradycardia, <span class="speceff-life">circulatory depression, cardiac arrest</span>. <span class="typehead">Special Senses:</span> Miosis, blurred vision. <span class="typehead">GI:</span> <span class="speceff-common">Nausea,</span> vomiting, constipation, ileus. <span class="typehead">Respiratory:</span> Laryngospasm, bronchoconstriction, <span class="speceff-life">respiratory depression or arrest</span>. <span class="typehead">Body as a Whole:</span> Muscle rigidity, especially muscles of respiration after rapid IV infusion, urinary retention, <span class="typehead">Skin:</span> Rash, contact dermatitis from patch. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Alcohol</b> and other <span class="classification">cns depressants</span> potentiate effects; <span class="classification">mao inhibitors</span> may precipitate hypertensive crisis. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Absorbed through the skin, leveling off between 1224 h. <span class="typehead">Onset:</span> Immediate IV; 715 min IM; 1224 h transdermal. <span class="typehead">Peak:</span> 35 min IV; 2472 h transdermal. <span class="typehead">Duration:</span> 3060 min IV; 12 h IM; 72 h transdermal. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine. <span class="typehead">Half-Life:</span> 17 h transdermal. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor vital signs and observe patient for signs of skeletal and thoracic muscle (depressed respirations) rigidity and weakness.</li>
<li>Watch carefully for respiratory depression and for movements of various groups of skeletal muscle in extremities, external
            eye, and neck during postoperative period. These movements may present patient management problems; report promptly.
         </li>
<li> 							Note: Duration of respiratory depressant effect may be considerably longer than narcotic analgesic effect. Have immediately available
            oxygen, resuscitative and intubation equipment, and an opioid antagonist such as naloxone. 						
         </li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>